UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

The New England journal of medicine, 2013-02, Vol.368 (7), p.623-632

2013

Volltextzugriff (PDF)

Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

The journal of clinical endocrinology and metabolism, 2006-02, Vol.91 (2), p.498-505

2006

Volltextzugriff (PDF)

Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management

Translational oncology, 2022-07, Vol.21, p.101445-101445, Article 101445

2022

Volltextzugriff (PDF)

Novel Approaches to Thyroid Cancer Treatment and Response Assessment

Seminars in nuclear medicine, 2016-03, Vol.46 (2), p.109-118

2016

Volltextzugriff (PDF)

Recombinant Human TSH-Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal

Journal of Nuclear Medicine, 2008-05, Vol.49 (5), p.764-770

2008

Volltextzugriff (PDF)

Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study

The Journal of nuclear medicine (1978), 2015-05, Vol.56 (5), p.662-667

2015

Volltextzugriff (PDF)

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

The journal of clinical endocrinology and metabolism, 2019-05, Vol.104 (5), p.1417-1428

2019

Volltextzugriff (PDF)

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

Clinical cancer research, 2023-04, Vol.29 (8), p.1620-1630

2023

Volltextzugriff (PDF)

Enhancing Radioiodine Incorporation in BRAF -Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial

Thyroid (New York, N.Y.), 2022-03, Vol.32 (3), p.273

2022

Volltextzugriff (PDF)

A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated thyroid cancer patients

Thyroid (New York, N.Y.), 2013-04, Vol.23 (4), p.436

2013

Volltextzugriff (PDF)

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Blood, 2022-10, Vol.140 (16), p.1822-1826

2022

Volltextzugriff (PDF)

Interobserver agreement of 18F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism

Thrombosis research, 2020-04, Vol.188, p.25-27

2020

Volltextzugriff (PDF)

Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases

Clinical nuclear medicine, 2018-02, Vol.43 (2), p.136-138

2018

Volltextzugriff (PDF)

Bone Scans, Bisphosphonates, and a Lack of Acute Changes Within the Mandible

Journal of oral and maxillofacial surgery, 2011, Vol.69 (1), p.114-119

2011

Volltextzugriff (PDF)

Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE

Neuroendocrinology, 2022-11, Vol.112 (12), p.1177-1186

2022

Volltextzugriff (PDF)

Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs

European journal of nuclear medicine and molecular imaging, 2024-01, Vol.51 (2), p.325-329

2024

Volltextzugriff (PDF)

The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients

European journal of nuclear medicine and molecular imaging, 2023-08, Vol.50 (10), p.2971-2983

2023

Volltextzugriff (PDF)

Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases

Thyroid (New York, N.Y.), 2014-07, Vol.24 (7), p.1088

2014

Volltextzugriff (PDF)

Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism

Chest, 2014-05, Vol.145 (5), p.1079-1088

2014

Volltextzugriff (PDF)

Enchondroma of Tibia as Potential False-positive Finding on 68Ga-DOTATOC PET/CT Scan

Clinical nuclear medicine, 2019-01, Vol.44 (1), p.e57

2019

Volltextzugriff (PDF)

Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET

The Journal of nuclear medicine (1978), 2003-11, Vol.44 (11), p.1789-1796

2003

Volltextzugriff (PDF)

Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation

Journal of Nuclear Medicine, 2009-10, Vol.50 (10), p.1605-1610

2009

Volltextzugriff (PDF)

The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification

Thyroid (New York, N.Y.), 2013-06, Vol.23 (6), p.683

2013

Volltextzugriff (PDF)

RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system

The Laryngoscope, 2015-10, Vol.125 (10), p.2417-2424

2015

Volltextzugriff (PDF)

Predicting malignancy in patients with adrenal tumors using 18F‐FDG‐PET/CT SUVmax

Journal of surgical oncology, 2020-12, Vol.122 (8), p.1821-1826

2020

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(68)
Buchkapitel
(5)

Sprache

Englisch
(73)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Female
(29)
Male
(29)
Middle Aged
(28)
Adult
(22)
Aged
(21)
Thyroid Neoplasms - Pathology
(14)
Iodine Radioisotopes - Therapeutic Use
(13)
Thyroid Cancer
(13)
Adolescent
(12)
Radiology, Nuclear Medicine & Medical Imaging
(12)
Oncology
(11)
Retrospective Studies
(11)
Endocrinology & Metabolism
(9)
Thyroid Neoplasms - Radiotherapy
(9)
Tomography, X-Ray Computed
(9)
Aged, 80 And Over
(8)
Radiopharmaceuticals
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management

Novel Approaches to Thyroid Cancer Treatment and Response Assessment

Recombinant Human TSH-Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal

Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET Study

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

Enhancing Radioiodine Incorporation in BRAF -Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial

A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated thyroid cancer patients

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma

Interobserver agreement of 18F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism

Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases

Bone Scans, Bisphosphonates, and a Lack of Acute Changes Within the Mandible

Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE

Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs

The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients

Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases

Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism

Enchondroma of Tibia as Potential False-positive Finding on 68Ga-DOTATOC PET/CT Scan

Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET

Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation

The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification

RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system

Predicting malignancy in patients with adrenal tumors using 18F‐FDG‐PET/CT SUVmax

Suchergebnisse filtern